Relation of the severity of mitral regurgitation to thromboembolic risk in patients with atrial fibrillation

International Journal of Cardiology

Volumn 146, Issue 2, 2011, Pages 197-201

  Fukuda, Nobuyuki ^a   Hirai, Tadakazu ^a   Ohara, Kazumasa ^a   Nakagawa, Keiko ^a   Nozawa, Takashi ^a   Inoue, Hiroshi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atrial fibrillation; D dimer; Mitral regurgitation; Transesophageal echocardiography

Indexed keywords

D DIMER;

AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THROMBOEMBOLISM;

EID: 78651437444     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.06.051     Document Type: Article

References (25)

1. Atrial Fibrillation Investigators Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Arch Intern Med 154 1994 1449 1457
2. H.J. Schunemann, D. Cook, and G. Guyatt Methodology for antithrombotic and thrombolytic therapy guideline development: American College of Chest Physicians Evidence-based Clinical Practice Guidelines (8th Edition) Chest 133 2008 122S 133S
3. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870
4. H. Inoue, T. Nozawa, and T. Hirai Accumulation of risk factors increases risk of thromboembolic events in patients with nonvalvular atrial fibrillation Circ J 70 2006 651 656
5. H. Fukazawa, K. Yamamoto, U. Ikeda, and K. Shimada Effect of mitral regurgitation on coagulation activity in atrial fibrillation Am J Cardiol 81 1998 93 96
6. H. Nakagami, K. Yamamoto, U. Ikeda, T. Mitsuhashi, T. Goto, and K. Shimada Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation Am Heart J 136 1998 528 532
7. G.T. Karatasakis, A.C. Gotsis, and D.V. Cokkinos Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease Am J Cardiol 76 1995 279 281
8. J. Vincelj, I. Sokol, and O. Jaksic Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography Echocardiography 19 2002 319 324
9. C. Movsowitz, H.D. Movsowitz, L.E. Jacobs, C.B. Meyerowitz, L.A. Podolsky, and M.N. Kotler Significant mitral regurgitation is protective against left atrial spontaneous echo contrast and thrombus as assessed by transesophageal echocardiography J Am Soc Echocardiogr 6 1993 107 114
10. Y. Wada, K. Mizushige, K. Ohmori, Y. Iwado, M. Kohno, and H. Matsuo Prevention of cerebral thromboembolism by low-dose anticoagulant therapy in atrial fibrillation with mitral regurgitation J Cardiovasc Pharmacol 37 2001 422 426
11. Y. Miyasaka, H. Tsuji, and S. Tokunaga Mild mitral regurgitation was associated with increased prevalence of thromboembolic events in patients with nonrheumatic atrial fibrillation Int J Cardiol 72 2000 229 233
12. F. Martini, A. Zuppiroli, and A.M. Gori Platelet and blood clotting activation in patients with mitral valve prolapse Thromb Res 83 1996 299 306
13. A. Lopez-Candales, and K.L. Edelman Large atrial appendage thrombus in the presence of severe mitral regurgitation: contradictory hemodynamics or expected findings Echocardiography 21 2004 525 529
14. H. Inoue, T. Nozawa, K. Okumura, J.D. Lee, A. Shimizu, and K. Yano Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism Chest 126 2004 687 692
15. T. Nozawa, H. Inoue, and T. Hirai D-dimer level influences thromboembolic events in patients with atrial fibrillation Int J Cardiol 109 2006 59 65
16. W.A. Zoghbi, M. Entriquez-Sarano, and E. Foster Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and doppler echocardiography J Am Soc Echocardiogr 16 2003 777 802
17. P.S. Douglas, C.B. Khandheria, and R.F. Stainback ACCF/ASE/ACEP/ASNC/ SCAI/ SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation/American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society for Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance J Am Soc Echocardiogr 20 2007 787 805
18. J.S. Gottdiener, J. Bednarz, and R. Devereux American Society of Echocardiography recommendations for use of echocardiography in clinical trials J Am Soc Echocardiogr 17 2004 1086 1119
19. D. Fatkin, R.P. Kelly, and M.P. Feneley Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo J Am Coll Cardiol 23 1994 961 969 (Pubitemid 24090884)
20. G.Y.H. Lip, L.A. Pearce, B.S.P. Chin, D.S.G. Conway, and R.G. Hart Effect of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibirillation Heart 91 2005 759 763
21. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation Ann Intern Med 128 1998 639 647
22. M. Zabalgoitia, J.L. Helperin, L.A. Pearce, J.L. Blackshear, R.W. Asinger, and R.G. Hart Transesophageal echocardiographic correlate of clinical risk of thromboembolism in nonvalvular atrial fibrillation J Am Coll Cardiol 128 1998 1622 1626
23. G.Y.H. Lip, P.L. Lip, and J. Zarifis Fibrin D-dimer and beta-thromboglobrin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin Circulation 94 1996 425 431
24. D. Fatkin, T. Loupas, and J. Low Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood Circulation 96 1997 889 896
25. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150